First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)

article

First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3389/FCVM.2019.00011
P932PMC publication ID6404544
P698PubMed publication ID30873413

P50authorFulvia CeccarelliQ86372522
Roberta PrioriQ87167983
Rolando CimazQ88307472
Elena ElefanteQ89789613
Chiara TaniQ89789616
Marta MoscaQ90560735
Andrea LojaconoQ91504092
Amelia RuffattiQ92104506
Marina MuscaràQ96066549
Salvatore De VitaQ114291040
Alessandro MathieuQ114314184
Melissa PadovanQ114314189
Ariela HoxhaQ114416255
Ma Tiziana BerteroQ114417396
Silvia BredaQ114417397
Marta TonelloQ114417398
Laura TrespidiQ114417399
Sonia ZattiQ114417400
Emma Di PoiQ114780706
Micaela FrediQ56468597
Antonio BrucatoQ57037188
Alessandra BortoluzziQ58328427
Laura AndreoliQ61806166
Véronique RamoniQ64015141
Franco FranceschiniQ69735842
Angela TincaniQ73304219
Matteo PigaQ37829183
Pier Luigi MeroniQ38544871
Marcello GovoniQ42410265
P2093author name stringStefano Calza
Maria Gerosa
Luca Marozio
Veronica Cappa
Antonina Minniti
Beatrice Bacco
P2860cites workCongenital heart block not associated with anti-Ro/La antibodies: comparison with anti-Ro/La-positive casesQ24653747
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationQ26765038
Clinical implications of glucocorticoid metabolism by 11beta-hydroxysteroid dehydrogenases in target tissuesQ31971105
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptorQ33335777
Effects of intravenous immunoglobulin on platelet count and antiplatelet antibody disposition in a rat model of immune thrombocytopenia.Q33343985
Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor.Q33346093
Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupusQ33770770
Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approachQ34283166
Proposal for a new definition of congenital complete atrioventricular block.Q35182018
Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus.Q35501152
Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.Q35546634
Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart diseaseQ35880901
Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupusQ36220831
Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodiesQ36570988
The rate of recurrence of isolated congenital heart block: a population-based studyQ73565865
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 womenQ74384559
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective studyQ80492903
Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control groupQ80845149
Identification of discrete epitopes of Ro52p200 and association with fetal cardiac conduction system manifestations in a rodent model.Q51557775
Plasmapheresis, intravenous immunoglobulins and bethametasone - a combined protocol to treat autoimmune congenital heart block: a prospective cohort study.Q51658934
Home Monitoring for Fetal Heart Rhythm During Anti-Ro PregnanciesQ57457905
Neonatal lupus: fetal myocarditis progressing to atrioventricular block in tripletsQ57745725
Primary Sjögren's syndrome--treatment of fetal incomplete atrioventricular block with dexamethasoneQ60548226
Plasma exchange effectively removes 52- and 60-kDa anti-Ro/SSA and anti-La/SSB antibodies in pregnant women with congenital heart blockQ61649461
Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodiesQ70301080
Concentration of autoantibodies to native 60-kd Ro/SS-A and denatured 52-kd Ro/SS-A in eluates from the heart of a child who died with congenital complete heart blockQ72857261
Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.Q37393128
Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedsideQ37404476
Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction systemQ37515813
The clinical spectrum of autoimmune congenital heart blockQ38387739
Description of 214 cases of autoimmune congenital heart block: Results of the French neonatal lupus syndromeQ38568964
Fluorinated steroids do not improve outcome of isolated atrioventricular blockQ39302351
Should we treat congenital heart block with fluorinated corticosteroids?Q40044899
Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational studyQ41936669
The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block.Q43790634
Isolated atrioventricular block in the fetus: a retrospective, multinational, multicenter study of 175 patientsQ46326249
Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institutionQ46335688
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectItalyQ38
congenital heart blockQ18558252
Risk factorsQ57237748
P304page(s)11
P577publication date2019-01-01
P1433published inFrontiers in cardiovascular medicineQ27726930
P1476titleFirst Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)
P478volume6

Reverse relations

cites work (P2860)
Q95841478Commentary: First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry)
Q97569121Congenital Heart Block in Subsequent Pregnancies of SSA/Ro-Positive Mothers: Cutting Recurrence in Half

Search more.